BG Medicine Profit Margin

BG Medicine (BGMD) currently reports a profit margin of -338.57% as of December 2015. That compares with -289.34% in the prior-year period — down 17.0% year over year. That is below the sector sector average of 13.16%. Use the charts on this page to explore BG Medicine's profit margin history and peer comparisons.

BG Medicine's profit margin decreased from -289.34% to -338.57% — a 17.0% year-over-year decrease (period ending December 2015). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BG Medicine's profit margin of -338.57% is lower than the its sector sector average of 13.16%. That is roughly 2672.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but BG Medicine's current -338.57% should be judged against industry norms (sector average: 13.16%) and against BGMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -338.57%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.16%. From there, open related valuation or income-statement pages for BG Medicine, and consider following BGMD for alerts when major investors trade the stock.